Insider Buy/Sell Ratio — Last 3 Months
Ratio0.2:1
Daily Buy & Sell Volume
By Sector
Technology
Buys619
Sells11257
Buy $$21.94B
Sell $$16.24B
Ratio1.35:1
% Change vs. Prior
Ratio +101.6%Value +169.3%
Healthcare
Buys603
Sells4791
Buy $$458.51M
Sell $$11.48B
Ratio1:25.04
% Change vs. Prior
Ratio -34.6%Value -22.9%
Industrials
Buys399
Sells2051
Buy $$356.72M
Sell $$7.34B
Ratio1:20.59
% Change vs. Prior
Ratio +145.3%Value +35.2%
Consumer Cyclical
Buys363
Sells2014
Buy $$1.12B
Sell $$4.04B
Ratio1:3.61
% Change vs. Prior
Ratio +21.4%Value +70.5%
Financial Services
Buys1255
Sells2814
Buy $$671.77M
Sell $$4.03B
Ratio1:6.00
% Change vs. Prior
Ratio -16.6%Value -22.1%
Energy
Buys300
Sells429
Buy $$99.59M
Sell $$4.56B
Ratio1:45.78
% Change vs. Prior
Ratio +42.0%Value -17.8%
Consumer Defensive
Buys160
Sells721
Buy $$137.72M
Sell $$2.07B
Ratio1:15.04
% Change vs. Prior
Ratio +99.3%Value +21.5%
Utilities
Buys67
Sells282
Buy $$74.86M
Sell $$1.38B
Ratio1:18.42
% Change vs. Prior
Ratio +20877.3%Value -78.8%
Communication Services
Buys139
Sells842
Buy $$166.16M
Sell $$1.25B
Ratio1:7.55
% Change vs. Prior
Ratio +132.7%Value +29.5%
Basic Materials
Buys134
Sells262
Buy $$62.92M
Sell $$680.59M
Ratio1:10.82
% Change vs. Prior
Ratio -56.0%Value -25.8%
Real Estate
Buys187
Sells321
Buy $$36.81M
Sell $$255.66M
Ratio1:6.95
% Change vs. Prior
Ratio -51.7%Value -27.5%
By Industry
Hardware, Equipment & Parts
Buys20
Sells1316
Buy $$21.63B
Sell $$834.37M
Ratio25.92:1
% Change vs. Prior
Ratio +221.1%Value +290.4%
Software - Infrastructure
Buys54
Sells3783
Buy $$33.48M
Sell $$5.07B
Ratio1:151.40
% Change vs. Prior
Ratio -71.9%Value +165.7%
Medical - Instruments & Supplies
Buys37
Sells110
Buy $$16.33M
Sell $$3.66B
Ratio1:224.11
% Change vs. Prior
Ratio +22.1%Value -52.3%
Biotechnology
Buys364
Sells3257
Buy $$390.86M
Sell $$2.98B
Ratio1:7.63
% Change vs. Prior
Ratio -52.5%Value +22.1%
Semiconductors
Buys111
Sells1822
Buy $$2.67M
Sell $$3.26B
Ratio1:1221.14
% Change vs. Prior
Ratio -80.0%Value +21.4%
Oil & Gas Exploration & Production
Buys176
Sells86
Buy $$48.68M
Sell $$2.63B
Ratio1:53.99
% Change vs. Prior
Ratio +404.4%Value -23.7%
Software - Application
Buys355
Sells1697
Buy $$266.96M
Sell $$2.39B
Ratio1:8.95
% Change vs. Prior
Ratio -65.0%Value +43.9%
Engineering & Construction
Buys13
Sells238
Buy $$1.90M
Sell $$2.34B
Ratio1:1232.64
Computer Hardware
Buys3
Sells1674
Buy $$104.50K
Sell $$2.29B
Ratio1:21947.85
Medical - Healthcare Information Services
Buys30
Sells313
Buy $$8.45M
Sell $$2.10B
Ratio1:248.87
% Change vs. Prior
Ratio -76.2%Value +17.5%
Rental & Leasing Services
Buys7
Sells109
Buy $$2.92M
Sell $$1.87B
Ratio1:641.97
Specialty Retail
Buys83
Sells971
Buy $$24.13M
Sell $$1.63B
Ratio1:67.42
% Change vs. Prior
Ratio -86.9%Value -15.9%
Information Technology Services
Buys60
Sells236
Buy $$9.67M
Sell $$1.40B
Ratio1:144.64
Shell Companies
Buys102
Sells256
Buy $$107.99M
Sell $$1.30B
Ratio1:12.00
% Change vs. Prior
Ratio +41.3%Value +47.5%
Leisure
Buys29
Sells107
Buy $$7.63M
Sell $$1.29B
Ratio1:169.74
Transactions (26023)
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
4,830
Price
$308.47
Total Value
$1.49M
Shares Held After
1,456,693
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
11,461
Price
$307.68
Total Value
$3.53M
Shares Held After
1,461,523
% of Holdings
0.8%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
589
Price
$306.33
Total Value
$180.43K
Shares Held After
1,472,984
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
544
Price
$304.81
Total Value
$165.82K
Shares Held After
1,473,573
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
176
Price
$303.17
Total Value
$53.36K
Shares Held After
1,474,117
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
640
Price
$302.24
Total Value
$193.43K
Shares Held After
1,474,293
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Krish S — Director
Shares
320
Price
$300.75
Total Value
$96.24K
Shares Held After
1,474,933
% of Holdings
0.0%
Leonardo DRS, Inc. (DRS)
Dorfman Mark — EVP, GC and Secretary
Shares
5,536
Price
$45.75
Total Value
$253.27K
Shares Held After
36,742
% of Holdings
13.1%
AXT INC (AXTI)
CHEN JESSE — Director
Shares
6,133
Price
$108.28
Total Value
$664.07K
Shares Held After
94,193
% of Holdings
6.1%
Vinci Compass Investments Ltd. (VINP)
Ribeiro Sergio Passos — Chief Financial Officer
Shares
4,047
Price
$9.79
Total Value
$39.62K
Shares Held After
250,776
% of Holdings
1.6%
MOHAWK INDUSTRIES INC (MHK)
HELEN SUZANNE L — Possible Member of Group
Shares
1,887
Price
$106.06
Total Value
$200.14K
Shares Held After
48,049
% of Holdings
3.8%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
240
Price
$311.65
Total Value
$74.80K
Shares Held After
1,378,155
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,039
Price
$310.94
Total Value
$634.00K
Shares Held After
1,378,395
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
2,801
Price
$309.95
Total Value
$868.16K
Shares Held After
1,380,434
% of Holdings
0.2%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
3,803
Price
$308.89
Total Value
$1.17M
Shares Held After
1,383,235
% of Holdings
0.3%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
12,729
Price
$307.81
Total Value
$3.92M
Shares Held After
1,387,038
% of Holdings
0.9%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
1,348
Price
$307.09
Total Value
$413.96K
Shares Held After
1,399,767
% of Holdings
0.1%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
480
Price
$305.87
Total Value
$146.82K
Shares Held After
1,401,115
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
400
Price
$304.89
Total Value
$121.96K
Shares Held After
1,401,595
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
247
Price
$303.17
Total Value
$74.88K
Shares Held After
1,401,995
% of Holdings
0.0%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
593
Price
$302.25
Total Value
$179.23K
Shares Held After
1,402,242
% of Holdings
0.0%
ICHOR HOLDINGS, LTD. (ICHR)
BARROS PHILIP RYAN SR. — Director
Shares
13,705
Price
$70.19
Total Value
$961.95K
Shares Held After
165,078
% of Holdings
7.7%
Krystal Biotech, Inc. (KRYS)
Krishnan Suma — Director
Shares
320
Price
$300.75
Total Value
$96.24K
Shares Held After
1,402,835
% of Holdings
0.0%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
100
Price
$9.00
Total Value
$900.00
Shares Held After
875,459
% of Holdings
0.0%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
8,939
Price
$37.09
Total Value
$331.54K
Shares Held After
64,620
% of Holdings
12.2%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
7,000
Price
$36.51
Total Value
$255.56K
Shares Held After
73,559
% of Holdings
8.7%
Arteris, Inc. (AIP)
Viana Antonio J — Director
Shares
4,900
Price
$35.47
Total Value
$173.78K
Shares Held After
80,559
% of Holdings
5.7%
Pacira BioSciences, Inc. (PCRX)
WILLIAMS KRISTEN — Chief Administrative Officer
Shares
10,259
Price
$22.27
Total Value
$228.47K
Shares Held After
167,062
% of Holdings
5.8%
TJX COMPANIES INC /DE/ (TJX)
Herrman Ernie — Director
Shares
28,000
Price
$158.32
Total Value
$4.43M
Shares Held After
524,850
% of Holdings
5.1%
NovoCure Ltd (NVCR)
Leonard Frank X — Chief Executive Officer
Shares
34,273
Price
$17.93
Total Value
$614.63K
Shares Held After
459,520
% of Holdings
6.9%
California Resources Corp (CRC)
Bys Jay A. — EVP & Chief Commercial Officer
Shares
11,907
Price
$61.68
Total Value
$734.42K
Shares Held After
171,331
% of Holdings
6.5%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
1,000
Price
$12.80
Total Value
$12.80K
Shares Held After
21,969
% of Holdings
4.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$12.68
Total Value
$6.34K
Shares Held After
22,969
% of Holdings
2.1%
CG Oncology, Inc. (CGON)
POST LEONARD E — Director
Shares
1,000
Price
$54.50
Total Value
$54.50K
Shares Held After
0
% of Holdings
100.0%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
826
Price
$87.91
Total Value
$72.61K
Shares Held After
802,708
% of Holdings
0.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
8,581
Price
$87.13
Total Value
$747.66K
Shares Held After
803,534
% of Holdings
1.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
10,992
Price
$86.07
Total Value
$946.08K
Shares Held After
812,115
% of Holdings
1.3%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
17,543
Price
$85.11
Total Value
$1.49M
Shares Held After
823,107
% of Holdings
2.1%
ACM Research, Inc. (ACMR)
Wang David H — Director
Shares
2,060
Price
$83.86
Total Value
$172.75K
Shares Held After
840,650
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$550.48
Total Value
$66.06K
Shares Held After
18,876
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,298
Price
$549.06
Total Value
$712.68K
Shares Held After
18,996
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,749
Price
$548.04
Total Value
$1.51M
Shares Held After
20,294
% of Holdings
11.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,033
Price
$547.00
Total Value
$565.05K
Shares Held After
23,043
% of Holdings
4.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,129
Price
$545.89
Total Value
$616.31K
Shares Held After
24,076
% of Holdings
4.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,545
Price
$544.94
Total Value
$841.94K
Shares Held After
25,205
% of Holdings
5.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,086
Price
$544.11
Total Value
$590.91K
Shares Held After
26,750
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
440
Price
$542.78
Total Value
$238.82K
Shares Held After
27,836
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
480
Price
$541.14
Total Value
$259.75K
Shares Held After
28,276
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
120
Price
$539.64
Total Value
$64.76K
Shares Held After
28,756
% of Holdings
0.4%
Xeris Biopharma Holdings, Inc. (XERS)
HALKUFF DAWN — Director
Shares
20,000
Price
$6.09
Total Value
$121.89K
Shares Held After
95,000
% of Holdings
17.4%
Showing 7501–7550 of 26023 transactions (page 151 of 521)